American Shared Hospital Services (AMS) Stock Price
AMSStock
$1.28−43.61%52W
Market Cap$8.51M
P/E4.08x
PEG Ratio—
Div yield—
Beta0.28
AMS Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-10.68%
Price vs S&P 500 (4W)-10.40%
VGM Score59.70
P/E Ratio (Annual)4.08x
AMS Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.02 | -$0.07 | -250.00%(-$0.05) | |
| Q1 2026 | -$0.01 | -$0.09 | -800.00%(-$0.08) | |
| Q4 2025 | $0.02 | -$0.09 | -550.00%(-$0.11) | |
| Q3 2025 | $0.00 | $0.00 | +0.00%(+$0.00) | |
| Q2 2025 | -$0.07 | -$0.04 | +42.86%(+$0.03) |
AMS Analyst Recommendations
Sep 2021
Oct 2021
Nov 2021
Dec 2021
4.00
4.00
4.00
4.00
Industry Peers — Health Services(30)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
AMSAmerican Shared Hospital Services | A | C | C | 4.1x | 4.0% | -11.8% | -7.5% | $1.28 |
| NTRANatera, Inc. Common Stock | F | A | A | — | 37.8% | -10.7% | -11.7% | $393.44 |
| DGXQuest Diagnostics Inc. | C | D | B | 26.1x | 9.9% | 14.1% | 14.5% | $235.00 |
| LHLabcorp Holdings Inc. | C | D | B | 29.4x | 6.4% | 10.4% | 11.6% | $317.95 |
| GHGuardant Health, Inc. Common Stock | F | A | B | — | 42.7% | -40.2% | -246.6% | $158.60 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | B | — | 38.5% | 12.7% | 18.8% | $30.56 |
| RDNTRadNet, Inc. Common Stock | D | C | C | 1779.3x | 18.9% | 3.0% | -1.9% | $68.80 |
| GRALGRAIL, Inc. Common Stock | D | B | B | — | 23.1% | -338.4% | -15.9% | $117.81 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | C | 621.1x | — | 10.9% | 8.9% | $98.12 |
| VCYTVeracyte, Inc. | D | B | C | 52.2x | 17.3% | 19.6% | 8.6% | $43.12 |
| CDNACareDx, Inc. | D | B | A | 18.3x | 34.4% | 23.6% | 32.8% | $64.00 |
About American Shared Hospital Services
American Shared Hospital Services supplies specialized radiation therapy equipment, including Gamma Knife stereotactic radiosurgery systems and advanced radiation therapy devices, to hospitals and standalone medical facilities. The company operates three main business segments: Gamma Knife systems, advanced radiation therapy equipment and services, and proton beam radiation therapy operations. Revenue is primarily generated from the domestic U.S. market.